AIM_ImmunoTech

AIM_ImmunoTech
Official AIM Representative

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of its lead product, Ampligen® (rintatolimod), for the treatment of late-stage pancreatic cancer, a lethal and unmet global health problem.

Strategy:
Joined Oct 2022

Advertisement|Remove ads.

Advertisement|Remove ads.

Advertisement|Remove ads.